The global pediatric psoriasis market was valued at USD 9.76 billion in 2019 and is expected to reach USD 21.38 billion by the year 2027, at a CAGR of 10.3%.
The global pediatric psoriasis market was valued at USD 9.76 billion in 2019 and is expected to reach USD 21.38 billion by the year 2027, at a CAGR of 10.3%. Psoriasis is one of the most common autoimmune disorders which causes skin cells to grow at a faster rate. The condition generally starts during early adulthood but can also affect children. According to the National Psoriasis Foundation, around 10% to 15% of people with psoriasis develop the condition before the age of 10 years.
There are various types of psoriasis that can affect children, the most common being plaque psoriasis. Plaque psoriasis is characterized by raised, red patches covered with a silvery-white build-up of dead skin cells. It can occur on any part of the body but is most commonly found on the scalp, knees, elbows, and lower back.
The global pediatric psoriasis market is expected to grow significantly over the forecast period owing to the increasing prevalence of the condition among children. According to a study published in The Journal of Pediatrics, the prevalence of psoriasis among children and adolescents in the United States was 1.6% in 2010-2011.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/52
The rising awareness about the condition and the availability of effective treatments are some of the other factors that are expected to boost the market growth over the forecast period. However, the high cost of treatment is expected to restraint the market growth during the forecast period.
Researchers in emerging economies have been expanding their focus on studying the prevalence and incidence of pediatric psoriasis in recent years. The aim is to provide better understanding of this disease so that more effective treatments can be devised in the future. Studies conducted in Brazil, China, and India have reported a significant increase in the number of children diagnosed with psoriasis each year. In addition, the number of children diagnosed with severe psoriasis is also on the rise.
This trend is likely to continue over the forecast period owing to the increasing awareness about this disease and its treatments, availability of better diagnostic facilities, and improvement in healthcare infrastructure in these countries.
Key Highlights from the Report
- However, treatment for pediatric psoriasis can be expensive and is not always covered by insurance plans. According to the National Psoriasis Foundation, the cost of treating psoriasis can range from $100 to $2,000 per month. In addition, there is currently no cure for psoriasis, which can lead to frustration and despair among patients.
- The plaque psoriasis segment is expected to register the fastest revenue CAGR during the forecast period due to the effectiveness and availability of topical, injectable, and oral therapies for plaque psoriasis.
- The topical therapy segment is expected to register the fastest revenue CAGR during the forecast period due to the favorable safety profiles of topical therapies. Also, the easy to use nature of topical therapies is another major factor that boosts the demand for these products. The injectable biologics segment held the largest market share in 2016 owing to their high efficacy and safety profiles.
- The Napkin or diaper psoriasis segment is expected to register the fastest revenue CAGR during the forecast period due to the higher prevalence of this type of psoriasis in children. Also, the lower availability of effective treatments for this type of psoriasis is likely to fuel market growth during the forecast period.
- According to a study published in 2016 by the National Psoriasis Foundation (NPF), napkin or diaper psoriasis is the most common type of childhood psoriasis, affecting up to 79% of children with the condition. The study also found that this type of psoriasis is more difficult to treat than other types of childhood psoriasis.
- The topical segment is expected to account for the largest share of the global pediatric psoriasis market in 2018. Topical treatments are generally the first line of treatment for pediatric psoriasis and are relatively safe and effective.
- The systemic segment is expected to register the fastest revenue growth during the forecast period, due to the increasing number of approvals for new systemic therapies for pediatric psoriasis. For instance, in September 2018, Cosentyx (secukinumab), a interleukin (IL)-17A inhibitor, was approved by the FDA for the treatment of pediatric patients aged six years and above with plaque psoriasis.
- North America is expected to account for the largest share of the global pediatric psoriasis market in 2018. This is attributed to factors such as the high prevalence of psoriasis in children, the availability of effective treatments, and the presence of a large number of market players in the region.
- The pediatric psoriasis market in Asia is expected to register the fastest revenue growth during the forecast period, due to factors such as the increasing incidence of psoriasis in children and the availability of new treatment options.
- Key participants include AbbVie Inc.; Amgen Inc.; Johnson & Johnson; Novartis AG; Eli Lilly & Company; AstraZeneca; Celgene Corporation; UCB; and Merck, Boehringer Ingelheim and LEO Pharma and others.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/pediatric-psoriasis-market
Emergen research have segmented into the global Pediatric psoriasis market on the basis of type, treatment, end use, and region:
Type Outlook (Revenue, USD million; 2017-2027)
- Plaque psoriasis
- Guttate psoriasis
- Pustular psoriasis
- Inverse psoriasis
- Erythrodermic psoriasis
- Mucosal/oral psoriasis
- Nail psoriasis
- Napkin or diaper psoriasis
- Photosensitive psoriasis
- Flexural psoriasis
Treatment Outlook (Revenue, USD million; 2017-2027)
- Topical therapy
- Oral
- Injections
- Biologics
- Natural supplements
- Phototherapy
End Use Outlook (Revenue, USD million; 2017-2027)
- Hospitals
- Specialty Clinics
- Ambulatory Care Centers
- Research Organizations
Regional Outlook (Revenue, USD million; 2017-2027)
- North America
- US.
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
- Brazil
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/52
Explore More Reports Emergen Research:
Automotive Airbag Silicone Market
Insulating Glass Window Market
Mobile Device Management Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-pediatric-psoriasis-market